Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor corepressor 1 (NCOR1) is a large, multi-domain scaffold protein that serves as a central hub for transcriptional repression. It functions by mediating the interaction between various nuclear receptors—such as the thyroid hormone receptor and retinoic acid receptor—and histone deacetylase complexes, specifically those containing HDAC3 (UniProt P42701). By recruiting these enzymes to target gene promoters, NCOR1 facilitates the removal of acetyl groups from histones, leading to chromatin condensation and the subsequent silencing of gene expression (PubMed: 21964338). This regulatory mechanism is vital for maintaining physiological balance in processes like metabolism, inflammation, and circadian rhythms. In clinical contexts, NCOR1 is frequently associated with the progression of various malignancies, including breast and prostate cancers, where it often acts as a tumor suppressor whose loss promotes hormone resistance and aggressive cellular behavior (PubMed: 29059175). Beyond oncology, its role in metabolic homeostasis makes it a significant factor in the development of obesity and insulin resistance (PubMed: 26829293). While NCOR1 is not typically the direct binding site for traditional small molecules, its function is central to the efficacy of HDAC inhibitors and selective nuclear receptor modulators. Recent drug discovery efforts have also begun exploring NCOR1 as a candidate for targeted protein degradation using PROTAC technology to selectively modulate transcriptional programs in disease states (PubMed: 33067605).
Recruitment of histone deacetylase 3 (HDAC3) and other corepressors to nuclear receptors and transcription factors to mediate gene silencing through chromatin remodeling (UniProt P42701).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor corepressor 1 (NCOR1) (NCOR1).